UNSPSC 51282611: Cefoselis sulfate

This classification denotes a cephalosporin antibiotic with the molecular formula C19H22N8O6S2.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6EY42207VS, chemically known as 5-amino-2-(((6r,7r)-7-(((z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)acetyl)-amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-1-(2-hydroxyethyl)-1h-pyrazolium hydroxide sulfate, but more generally known as cefoselis sulfate, which bears US NIH Compound Identifier 9690118.

European Medicines Agency schedules cefoselis sulfate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07404MIG. Most nations, for tariff purposes, schedule cefoselis sulfate under HS 29419000. SMILES: CO/N=C(/C1CSC(N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CN4CCC(=N)N4CCO)C(=O)O.OS(=O)(=O)O.

UNSPSC 51282611 Cefoselis sulfate, a Commodity code, nominally identifies a specific injectable antibiotic active pharmaceutical ingredient, but the recent state and local opportunities tagged under this code show limited direct procurement activity for cefoselis itself. The opportunities actually solicited involve broader pharmaceutical supply — antibiotic tablets (doxycycline and ciprofloxacin), naloxone, and drug deactivation systems — suggesting that state and local buying entities use this code as a catch-all for pharmaceutical warehouse and emergency-medicine stockpile contracts rather than for cefoselis specifically. The issuing bodies include state health departments and county public-health agencies pursuing piggyback and cooperative-purchasing vehicles to supply established pharmaceutical inventories and emergency-response supplies.

Activity appears concentrated in states with active cooperative purchasing arrangements and public-health procurement programs. The Illinois Department of Public Health awarded a piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC (completed August 28, 2026, IFB process) for pharmaceutical warehouse supply worth $2,999,999.11 over three years; Seminole County, Florida posted an IFB (due July 26, 2023, though this date is in the past relative to today's date) for 1,900 units of naloxone and 800 drug deactivation systems annually. Both opportunities reflect procurement through established vendor networks and cooperative agreements rather than open competitive bidding for cefoselis as an individual line item. The code shows little evidence of direct commodity-level purchasing for cefoselis in the recent state and local market.